The clinical trials below are available in the specialty you selected. Choose a different specialty.
Multicenter, Blinded Efficacy and Safety Study of Pasireotide LAR vs Octreotide LAR in Patients With Metastatic Carcinoid Tumors Whose Disease-Related Symptoms Are Inadequately Controlled by Somatostatin Analogues
Participate in a study for patients with metastatic carcinoid tumors whose disease-related symptoms are inadequately controlled by somatostatin analogues. (REF# 7293)
A Prospective Randomized Phase III Translational NIH Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
This study seeks adult cancer patients to determine if a daily injection of a blood-thinner, dalteparin, for three months can safely and effectively reduce the frequency of blood clots in patients at increased risk. (REF# 11739)